Industry insights, October 2025

This month has seen a number of exciting discoveries and noteworthy advancements in the nucleic acid therapeutics space. Along with our recent infographic—Oligotherapeutics: status quo and future outlook—which discusses the current landscape and future directions in oligonucleotide-based therapies, our new Nucleic Acid Insights Industry Insights series will present the latest updates and developments from across the nucleic acids space, including new collaborations accelerating RNA-based drug development, innovative manufacturing platforms, progress in clinical trials for rare and cardiovascular diseases, emerging AI and gene-editing tools, and regulatory updates supporting novel nucleic acid therapies.